Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
FASEB J ; 35(2): e21367, 2021 02.
Artigo em Inglês | MEDLINE | ID: mdl-33508160

RESUMO

Millions of human deaths occur annually due to chronic kidney disease, caused by diabetic kidney disease (DKD). Despite having effective drugs controlling the hyperglycemia and high blood pressure, the incidence of DKD is increasing, which indicates the need for the development of novel therapies to control DKD. In this article, we discussed the recent advancements in the basic innate immune mechanisms in renal tissues triggered under the diabetes environment, leading to the pathogenesis and progression of DKD. We also summarized the currently available innate immune molecules-targeting therapies tested against DKD in clinical and preclinical settings, and highlighted additional drug targets that could potentially be employed for the treatment of DKD. The improved understanding of the disease pathogenesis may open avenues for the development of novel therapies to rein in DKD, which consequently, can reduce morbidity and mortality in humans in the future.


Assuntos
Nefropatias Diabéticas/imunologia , Nefropatias Diabéticas/patologia , Imunidade Inata , Animais , Nefropatias Diabéticas/fisiopatologia , Nefropatias Diabéticas/terapia , Humanos , Imunidade Inata/efeitos dos fármacos , Imunidade Inata/imunologia , Terapia de Alvo Molecular/tendências
2.
Dermatol Ther ; 33(6): e14415, 2020 11.
Artigo em Inglês | MEDLINE | ID: mdl-33064363

RESUMO

Vitiligo is a common and refractory disease worldwide. The limited efficiency and side effects of the conventional treatment options create demands towards the development of strategies. Excellent repigmentation is demonstrated after several filiform fire needle sessions in the vitiligo lesions. In this observational study, we aimed to observe the response to filiform fire needle therapy in patients with vitiligo, and determine whether there was a difference of efficiency with respect to the type, affected site, and disease duration of vitiligo. Patients received filiform fire needle therapy once every 2 weeks for 12 consecutive weeks. The results of the 77 vitiligo patients were: 34 (44.15%) with an excellent repigmentation rate, 15 (19.48%) with a marked improvement, 15 (19.48%) with a moderate response, 6 (7.79%) with a slight improvement, and 7 (9.09%) with an absent response. Among the vitiligo patients with different affected sites, the most effective location of therapy was the face. Shorter course leads to better therapeutic effect. Two patients developed hypertrophic scars on the lesion site. In conclusion, this study shows filiform fire needle therapy is an effective and relatively safe therapeutic option for vitiligo.


Assuntos
Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos , Vitiligo , Face , Humanos , Agulhas , Estudos Retrospectivos , Resultado do Tratamento , Vitiligo/diagnóstico , Vitiligo/terapia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...